Brief: Kala Pharmaceuticals Announces Positive Safety Update From Cohort 1 Of Chase Phase 2B Clinical Trial Evaluating Kpi-012 In Patients With PCED

KALA BIO

27/03/2023 13:42

March 27 (Reuters) - Kala Pharmaceuticals Inc  KALA.O :
    * KALA PHARMACEUTICALS ANNOUNCES POSITIVE SAFETY UPDATE FROM
COHORT 1 OF CHASE PHASE 2B CLINICAL TRIAL EVALUATING KPI-012 IN
PATIENTS WITH PCED
    * KALA PHARMACEUTICALS INC - NO SAFETY ISSUES IDENTIFIED IN
COHORT
1
    * KALA PHARMACEUTICALS INC - TOPLINE DATA FOR COHORT 2
TARGETED
FOR 1Q 2024

Source text for Eikon:  ID:nGNXWyTWM 
Further company coverage:  KALA.O 

 ((Reuters.Briefs@thomsonreuters.com;))